![]() Ziemanski JF, Wolters LR, Jones-Jordan L, Nichols JJ, Nichols KK. Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration. Circulating omega-3 Fatty acids and neovascular age-related macular degeneration. Docosahexaenoic acid and adult memory: a systematic review and meta-analysis. Yurko-Mauro K, Alexander DD, Van Elswyk ME. Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: a systematic review and meta-analysis of randomized controlled trials. Jiao J, Li Q, Chu J, Zeng W, Yang M, Zhu S. Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis. Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. Dietary guidelines of Americans: 2020-2025.Īmerican Academy of Pediatrics Section on Breastfeeding. Omega-3 long chain polyunsaturated fatty acids to prevent preterm birth: a systematic review and meta-analysis. Maternal fish intake during pregnancy, blood mercury levels, and child cognition at age 3 years in a US cohort. Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: A science advisory from the American Heart Association. Siscovick DS, Barringer TA, Fretts AM, et al. Seafood long-chain n-3 polyunsaturated fatty acids and cardiovascular sisease: A science advisory from the American Heart Association. Marine omega-3 supplementation and cardiovascular disease: an updated meta‐analysis of 13 randomized controlled trials involving 127 477 participants. n-3 fatty acids and cardiovascular events after myocardial infarction. Kromhout D, Giltay EJ, Geleijnse JM Alpha Omega Trial Group. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. ORIGIN Trial Investigators, Bosch J, Gerstein HC, et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. New insights into mechanisms of action for omega-3 fatty acids in atherothrombotic cardiovascular disease. Omega-3 fatty acids: Fact sheet for consumers. National Institutes of Health: Office of Dietary Supplements.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |